Center for Oncology Research & Treatment–Dallas, TX. Innovative Cancer Treatment. « Metastatic Breast Cancer Studies Testing mTOR Inhibitor RAD001 to begin at CORT. First-Line Chemotherapy Study for Her-2 Negative Metastatic Breast …
Excerpt from:
First-Line Chemotherapy Study for Her-2 Negative Metastatic Breast …
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
You must log in to post a comment.